News
Discover the latest news and developments in AI and machine learning happening in the image-guided therapy (IGT) sector in Canada.
Cohesic flips the script on incorporating AI into healthcare
Jordan Engbers, Chief Science Officer of Cohesic, a data scientist who spent years in clinical research, is painfully aware of the chasm between the promise and reality of AI in healthcare. While an AI model might work within a study where researchers systematically gather, clean up, and standardize the data, real-world healthcare data is often too messy and unreliable to use for clinical decisions.
How 16 Bit harnessed AI to prevent costly fractures, one X-ray at a time
As with many transformative businesses, 16 Bit came to be because of, sure, the brilliance and vision of its founders, but also a great deal of serendipity. 16 Bit might not exist had Dr. Mark Cicero and Dr. Alexander Bilbily not both chosen to pursue medical school (with backgrounds in engineering and computer science, respectively), had they not both decided to specialize in radiology, and had they not ended up in the same residency training program at the University of Toronto.
INOVAIT reveals Canada’s strategic advantages in image-guided therapy and artificial intelligence in latest report
INOVAIT, the pan-Canadian innovation network supporting advancements and commercialization in image-guided therapy (IGT) and artificial intelligence (AI), is excited to share their latest report titled, ‘Unlocking Medtech’s Potential: Canada’s Strategic Advantages in Image-Guided Therapy & AI’. Through synthesized insights from interviews with founders and executives from 30 IGT companies in the INOVAIT Network, this new report uncovers the untapped potential of the image-guided therapy sector in Canada.
Network News
INOVAIT awards two leading companies and one academic partner for transforming Canada’s healthcare ecosystem
TORONTO, April 25, 2024 /CNW/ - INOVAIT, the national network for commercializing breakthroughs in image-guided...
2024 Discovery Forum Recap
Last week, we hosted our 3rd annual Discovery Forum and welcomed our esteemed members from across the country to Torys...
Tenomix secures oversubscribed $2.1M, all-Canadian financing round to advance cancer staging
Tenomix, an image-guided diagnostic company based out of Western University’s BioNext Medtech Incubator, recently celebrated a significant milestone with an oversubscribed all-Canadian $2.14M funding round. Established in 2021 by four alums of WORLDiscoveries’ Medical Innovation Fellowship program at Western University, Tenomix is transforming cancer staging, particularly in colorectal cancer, with its innovative approach.
PulseMedica is laser-focused on tackling vitreoretinal diseases
The PulseMedica platform is a 3D image-guided therapy device that integrates powerful laser therapy, advanced medical imaging, and limitless machine learning (ML) for precision imaging and treatment of vitreoretinal disease. Vitreoretinal diseases exist within the clear gel (vitreous fluid) that fills the eye and retina at the back of the eye. PulseMedica’s device strives to automate the imaging and treatment process, enabling quick and precise disease targeting, thereby reducing the treatment time and reducing the risk of side effects and total time per patient, allowing for more patients to be treated each day.
IGT Lecture Series
Regulating AI in Image-Guided Therapy
Follow INOVAIT on Social Media
The Network in the Press
